Search research articles
Contact Us
Filters
Showing results (21-30 of 67) with videos related to
Page
of 7
Sort By:
British Journal of Haematology
|
April 2, 2020
The anti-mitotic agents PTC-028 and PTC596 display potent activity in pre-clinical models of multiple myeloma but challenge the role of BMI-1 as an essential tumour gene
Arnold Bolomsky, Joséphine Muller, Kathrin Stangelberger, et al.
Human Molecular Genetics
|
January 14, 2016
Pharmacologically induced mouse model of adult spinal muscular atrophy to evaluate effectiveness of therapeutics after disease onset
Zhihua Feng, Karen K Y Ling, Xin Zhao, et al.
Plos One
|
March 9, 2016
SMN Protein Can Be Reliably Measured in Whole Blood with an Electrochemiluminescence (ECL) Immunoassay: Implications for Clinical Trials
Phillip Zaworski, Katharine M von Herrmann, Shannon Taylor, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2023
Reduction of retinal ganglion cell death in mouse models of familial dysautonomia using AAV-mediated gene therapy and splicing modulators
Anastasia Schultz, Shun-Yun Cheng, Emily Kirchner, et al.
Scientific Reports
|
October 31, 2023
Reduction of retinal ganglion cell death in mouse models of familial dysautonomia using AAV-mediated gene therapy and splicing modulators
Anastasia Schultz, Shun-Yun Cheng, Emily Kirchner, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 21, 2013
Discovery of N-(4'-(indol-2-yl)phenyl)sulfonamides as novel inhibitors of HCV replication
Guangming Chen, Hongyu Ren, Anthony Turpoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 29, 2024
Phase Ib Study of Unesbulin (PTC596) Plus Dacarbazine for the Treatment of Locally Recurrent, Unresectable or Metastatic, Relapsed or Refractory Leiomyosarcoma
Brian A Van Tine, Matthew A Ingham, Steven Attia, et al.
Annals of Clinical and Translational Neurology
|
December 12, 2025
Exploratory Analysis of ELP1 Expression in Whole Blood From Patients With Familial Dysautonomia
Alejandra González-Duarte, Lucy Norcliffe-Kaufmann, Maria Luisa Cotrina, et al.
Clinical Pharmacology in Drug Development
|
January 13, 2021
Pharmacokinetics and Safety of PTC596, a Novel Tubulin-Binding Agent, in Subjects With Advanced Solid Tumors
Geoffrey I Shapiro, Edward O'Mara, Oscar L Laskin, et al.
Transplantation
|
June 4, 2002
T-cell depletion and graft survival induced by anti-human CD3 immunotoxins in human CD3epsilon transgenic mice
Marla Weetall, Mary Ellen Digan, Ronald Hugo, et al.
Page
of 7
Search research articles
Search
Showing results (21-30 of 67) with videos related to
Sort By:
Page
of 7
British Journal of Haematology
|
April 2, 2020
The anti-mitotic agents PTC-028 and PTC596 display potent activity in pre-clinical models of multiple myeloma but challenge the role of BMI-1 as an essential tumour gene
Arnold Bolomsky, Joséphine Muller, Kathrin Stangelberger, et al.
Human Molecular Genetics
|
January 14, 2016
Pharmacologically induced mouse model of adult spinal muscular atrophy to evaluate effectiveness of therapeutics after disease onset
Zhihua Feng, Karen K Y Ling, Xin Zhao, et al.
Plos One
|
March 9, 2016
SMN Protein Can Be Reliably Measured in Whole Blood with an Electrochemiluminescence (ECL) Immunoassay: Implications for Clinical Trials
Phillip Zaworski, Katharine M von Herrmann, Shannon Taylor, et al.
Biorxiv : the Preprint Server for Biology
|
June 9, 2023
Reduction of retinal ganglion cell death in mouse models of familial dysautonomia using AAV-mediated gene therapy and splicing modulators
Anastasia Schultz, Shun-Yun Cheng, Emily Kirchner, et al.
Scientific Reports
|
October 31, 2023
Reduction of retinal ganglion cell death in mouse models of familial dysautonomia using AAV-mediated gene therapy and splicing modulators
Anastasia Schultz, Shun-Yun Cheng, Emily Kirchner, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 21, 2013
Discovery of N-(4'-(indol-2-yl)phenyl)sulfonamides as novel inhibitors of HCV replication
Guangming Chen, Hongyu Ren, Anthony Turpoff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 29, 2024
Phase Ib Study of Unesbulin (PTC596) Plus Dacarbazine for the Treatment of Locally Recurrent, Unresectable or Metastatic, Relapsed or Refractory Leiomyosarcoma
Brian A Van Tine, Matthew A Ingham, Steven Attia, et al.
Annals of Clinical and Translational Neurology
|
December 12, 2025
Exploratory Analysis of ELP1 Expression in Whole Blood From Patients With Familial Dysautonomia
Alejandra González-Duarte, Lucy Norcliffe-Kaufmann, Maria Luisa Cotrina, et al.
Clinical Pharmacology in Drug Development
|
January 13, 2021
Pharmacokinetics and Safety of PTC596, a Novel Tubulin-Binding Agent, in Subjects With Advanced Solid Tumors
Geoffrey I Shapiro, Edward O'Mara, Oscar L Laskin, et al.
Transplantation
|
June 4, 2002
T-cell depletion and graft survival induced by anti-human CD3 immunotoxins in human CD3epsilon transgenic mice
Marla Weetall, Mary Ellen Digan, Ronald Hugo, et al.
Page
of 7